Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: sammaster who wrote (77058)	3/6/2000 3:20:00 PM
From: epicure	Respond to of 132070

enquiring minds I think he said he found it in the National Enquirer. I know I'm getting a subscription. Who needs the WSJ.

To: sammaster who wrote (77058)	3/6/2000 6:33:00 PM
From: Knighty Tin	Read Replies (1) \| Respond to of 132070

Samir, Well, I have a medical background in that I was born in a hospital. <VBG> No, the simple fact is potential vs. price. I first started buying puts on and shorting biotechs after the 1992 election and made a ton of money on the downside. But then they got too low for any sensible person and I started buying. I've feel that there is always a trade long either information techs or biotechs and long puts on the other. They are both sectors that tend to trade on emotions. I have been researching biotechs since they've been in existence, but I don't claim any scientific knowledge. I just go for the companies that make me believe they have a good product pipeline, control of their finances and cheap stock. Then I buy a basket of them. The winners win so big that the losers (hello, Shaman <g>) are only remembered by curmudgeons such as myself who cannot stand to lose a nickle. Essentially, though, I treat biotechs like other growth groups. I buy them when the valuations look reasonable and everyone hates them. I have been lightening the list lately. Praise the Lord and pass the ammunition. <g>